Johnny Johnson

I have two projects that I am seeking investment funding for. The first project is a technology that will restore sight to the blind. People that suffer from macular degeneration, retinitis pigmentosa, and diabetic retinopathy will benefit. The other technology can eliminate the need for a person to take a blood test to evaluate their illness. The other nanotechnology can provide an innovative approach to improve the quality and convenience of medical diagnosis and data transmission for immediate therapy. Characteristic odors accompany many diseases. Their recognition can provide diagnostic clues, guide the laboratory evaluation, and affect the choice of immediate therapy. The study of the chemical composition of human breath using gas chromatography-mass spectrometry has shown a correlation between volatile compounds and the occurrence of certain illnesses. The presence of these specific compounds can indicate a physiological malfunction and support the diagnosis of diseases. This condition requires an analytical tool with very high sensitivity for its measurement.